Skip to content
Search

Latest Stories

England dispensed 1.11 billion prescription items in 2020-21

The cost of prescription items dispensed in England in 2020-21 was £9.61 billion, a 3.49 per cent increase of £324 million from £9.28 billion in the previous year.

"This is the second consecutive year that the cost of items dispensed in England has increased following three consecutive years of decreases between 2015-16 and 2018-19," the NHS Business Services Authority (NHSBSA) said as it published its annual prescription cost analysis (PCA) today (June 10).


The number of prescription items dispensed was 1.11 billion, a 1.90 per cent decrease of 21.5 million items from 1.13 billion in 2019-20.

Atorvastatin, a 'statin' mainly used in lowering cholesterol in people suffering from high blood cholesterol or in prevention of heart disease, was found to be the most dispensed drug in England in 2020-21 with 49.9 million items.

Apixaban, an anticoagulant to prevent blood clots, was the drug with highest cost of £356 million.

Sertraline 100 mg (an antidepressant) tablet was the presentation with the "largest increase in cost between 2019-20 and 2020-21 of £78.9 million, from £21.0 million to £99.9 million."

As per the analysis, the cost of Sertraline increased by 376 per cent between 2019-20 and 2020-21, while the number of items prescribed increased by 7.51 per cent.

More For You

Confirm Pharmacy First Funding beyond April- Helen Morgan MP urges health secretary

North Shropshire MP Helen Morgan

Helen Morgan MP calls on Wes Streeting to clarify Pharmacy First’s future

Liberal Democrat health and care spokesperson Helen Morgan has urged the government to provide clarity on the future of Pharmacy First and confirm continued funding beyond April.

In a letter to health secretary Wes Streeting, the North Shropshire MP expressed deep concern over the uncertainty surrounding the initiative, which plays a crucial role in shifting healthcare services into communities.

Keep ReadingShow less
NHS England restructures leadership with new executive team

Except for the deputy chief executive officer, all team members will assume their roles on 1 April 2025.

Getty Images

NHS England announces new executive team to lead transformation

Sir James Mackey will be leading NHS England’s transition into the Department of Health and Social Care (DHSC), along with the incoming team.

He will officially take up the role as the new chief executive officer of NHS England on 1 April 2025, replacing Amanda Pritchard, who is stepping down at the end of this month.

Keep ReadingShow less
Community Pharmacies advised to reduce opening hours and services

Community Pharmacies advised to reduce opening hours and services

Breaking news: Pharmacies advised to reduce opening hours and services from April 1st

The government has been warned that community pharmacies will take collective action and reduce opening hours and services from April 1st unless there is an imminent clarity on a new funding contract.

The National Pharmacy Association (NPA) on Tuesday (17) announced that will advise its 6000 member pharmacies in England to take the unprecedented step in the face of what it has described as an April cliff-edge that will see a range of financial burdens placed on the sector.

Keep ReadingShow less
More patients on weight-loss injections undergoing gallbladder removal, warns pharmacist

Weight-loss injections can make bile more sludgy and even lead to the formation of gallstones

GettyImages

Weight-loss injections can cause gallstones, warns pharmacist

A leading pharmacist has raised concerns over a rise in gallbladder issues among individuals using weight-loss injections, particularly Eli Lilly’s Mounjaro (tirzepatide).

Deborah Grayson, a pharmacist and nutritional therapist, shared an alert in a TikTok video, highlighting the potential effects of weight-loss injections on gallbladder health.

Keep ReadingShow less
 Gordons Chemists sells Scottish pharmacies to focus on home market

Gordons Chemist in Helensburgh

Image credit: Christie & Co

Gordons Chemists exits Scottish market to focus on Northern Ireland network

Gordons Chemists, Northern Ireland’s largest independent pharmacy chain, has sold all nine of its Scottish pharmacies as part of a strategic decision to refocus on its home market.

Broker Christie & Co recently announced the sale of the pharmacies, located in Helensburgh, Alexandria, Milngavie, Cowdenbeath, Musselburgh, Edinburgh, Armadale, Stranraer, and Oban.

Keep ReadingShow less